Our findings further support the role of Nrf2 in the regulation of pirin expression by showing that genetic or pharmacologic Nrf2 activation enhances pirin expression, whereas Nrf2 deletion or disruption has the opposite effect in several experimental systems, and that the overexpression of pirin in human colorectal tumours correlates with Nrf2 activation. This evidence concerns the gene PIR and colorectal neoplasm.